Browsing "1. Journal Papers" by Author : 2426

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 12 of 12

This table browses all dspace content
Issue DateTitleJournal Title
2018A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and ChemotherapyAAPS JOURNAL
2022A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer NATURE COMMUNICATIONS
2011Advanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysis. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
2019Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea CANCER RESEARCH AND TREATMENT
2021Detection of asymptomatic recurrence improves survival of gastric cancer patients CANCER MEDICINE
2012External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer ANNALS OF ONCOLOGY
2023Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea JOURNAL OF GASTRIC CANCER
2024Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer StudyJOURNAL OF CLINICAL ONCOLOGY
2018Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea CANCER RESEARCH AND TREATMENT
2019Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancerEUROPEAN JOURNAL OF CANCER
2024Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II studyGASTRIC CANCER
2023Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction CancerJOURNAL OF CLINICAL ONCOLOGY
1

Browse

Links